By Counterforce Health Team in Ofev (nintedanib) —

How to Get Ofev (nintedanib) Covered by UnitedHealthcare in Pennsylvania: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Ofev Approved by UnitedHealthcare in Pennsylvania

UnitedHealthcare requires prior authorization for Ofev (nintedanib) with specific criteria: pulmonologist prescription, confirmed IPF/SSc-ILD/progressive fibrosing ILD diagnosis, HRCT evidence of fibrosis, and PFT decline documentation. Submit via the UnitedHealthcare provider portal with complete clinical records. If denied, Pennsylvania's new external review program has overturned 50% of appealed denials in 2024. First step today: Verify your plan type (commercial vs. self-funded) and gather HRCT reports and pulmonary function tests from the past 6-12 months.

Table of Contents

  1. What This Guide Covers
  2. Before You Start: Plan Verification
  3. Gather What You Need
  4. Submit the Prior Authorization Request
  5. Follow-Up and Timeline Expectations
  6. If You're Asked for More Information
  7. If Your Request is Denied
  8. Pennsylvania's External Review Process
  9. Renewal and Re-Authorization
  10. Cost Assistance Options
  11. Quick Reference Checklist

What This Guide Covers

This comprehensive guide helps patients with idiopathic pulmonary fibrosis (IPF), systemic sclerosis-associated interstitial lung disease (SSc-ILD), or progressive fibrosing interstitial lung disease navigate UnitedHealthcare's prior authorization process for Ofev (nintedanib) in Pennsylvania.

Ofev is an oral antifibrotic medication that slows lung function decline in these serious conditions. With cash prices typically ranging $13,000-$15,000 per month, securing insurance coverage is essential. UnitedHealthcare requires prior authorization, but with proper documentation and Pennsylvania's strengthened appeals process, approval rates are improving.

Counterforce Health helps patients and clinicians turn insurance denials into successful appeals by creating evidence-backed, payer-specific rebuttal letters. Their platform analyzes denial reasons and drafts targeted responses using the right clinical evidence and procedural requirements for each insurer.

Before You Start: Plan Verification

Confirm Your Plan Type

First, determine if you have a commercial insured plan or a self-funded employer plan. This affects your appeal rights in Pennsylvania:

  • Commercial insured plans: Eligible for Pennsylvania's external review process
  • Self-funded employer plans: Subject to federal ERISA rules only

Check your insurance card or call the member services number to verify. Most individual and small group plans are commercially insured.

Coverage at a Glance

Requirement Details Where to Find It
Prior Authorization Required for all indications UnitedHealthcare PA policy
Formulary Tier Tier 3 specialty (varies by plan) Member portal or formulary document
Step Therapy May require pirfenidone trial first Plan-specific; check denial letter
Prescriber Requirement Must be pulmonologist UnitedHealthcare PA criteria
Quantity Limits Possible supply restrictions Plan formulary
Appeals Deadline 180 days from denial UnitedHealthcare policy

Gather What You Need

Essential Documentation

Clinical Records (Required)

  • High-resolution CT (HRCT) scan reports showing fibrosis pattern
  • Pulmonary function tests (PFTs) documenting decline over 6-24 months
  • Pulmonologist consultation notes with diagnosis confirmation
  • ICD-10 codes (J84.112 for IPF; others for SSc-ILD/CF-ILD)

Prior Treatment Documentation

  • Records of previous therapies tried and failed (if step therapy applies)
  • Contraindication documentation for alternative treatments
  • Adverse event reports from prior medications

Insurance Information

  • Member ID and policy details
  • Current formulary status for Ofev
  • Any previous denial letters
Tip: Request medical records early. Clinics may need 5-10 business days to compile comprehensive documentation.

Clinician Corner: Medical Necessity Letter

Your pulmonologist should include these elements in their prior authorization request:

Problem Statement: Clear diagnosis with ICD-10 code and disease severity Clinical History: Symptom progression, functional decline, imaging changes Prior Treatments: What was tried, duration, outcomes, reasons for discontinuation Rationale: Why Ofev is medically necessary and appropriate Guidelines: Citations to FDA labeling and ATS/ERS guidelines Monitoring Plan: How response will be assessed and safety monitored

Submit the Prior Authorization Request

Step-by-Step Submission Process

1. Provider Initiates Request (Days 1-2) Your pulmonologist submits via the UnitedHealthcare provider portal or calls 888-397-8129. Include all clinical documentation with the initial submission.

2. OptumRx Review Begins (Days 3-5) UnitedHealthcare's pharmacy benefit manager reviews against their PA criteria. Some approvals may be automated if criteria are clearly met.

3. Decision Notification (Days 5-7) Standard decisions within 72 hours; urgent requests within 24 hours. Approval includes specialty pharmacy routing to OptumRx.

UnitedHealthcare PA Criteria for Ofev

For IPF (Initial 12-month authorization):

  • Confirmed IPF diagnosis (ICD-10 J84.112)
  • Exclusion of other ILD causes
  • Pulmonologist prescriber
  • HRCT evidence of fibrosis
  • PFT decline or clinical progression

For SSc-ILD:

  • Systemic sclerosis with skin thickening or specific antibodies
  • HRCT evidence of ILD
  • FVC 40-80% predicted
  • Pulmonologist prescriber

For Progressive Fibrosing ILD:

  • Fibrotic ILD on HRCT
  • At least 2 of: FVC decline ≥5%, worsening symptoms, new fibrosis on imaging
  • Documented over 24 months
  • Not combined with Esbriet (pirfenidone)

Follow-Up and Timeline Expectations

What to Expect

  • Standard review: 72 hours
  • Urgent/expedited: 24 hours
  • Incomplete submissions: May delay decision by 5-10 days

Sample Call Script for Status Check

"Hello, I'm calling to check the status of a prior authorization for Ofev (nintedanib) for [patient name], member ID [number]. The request was submitted on [date]. Can you provide the current status and any reference number?"

Document all interactions with dates, representative names, and reference numbers.

If You're Asked for More Information

UnitedHealthcare may request additional documentation. Common requests include:

  • More detailed progression data: Serial PFTs showing specific decline percentages
  • Step therapy documentation: Proof of pirfenidone trial/failure if required
  • Specialist confirmation: Additional pulmonologist attestation
  • Imaging clarification: Radiologist report confirming fibrosis pattern

Respond promptly to avoid delays. The Counterforce Health platform can help identify exactly what evidence payers need and format it appropriately.

If Your Request is Denied

Common Denial Reasons and Solutions

Denial Reason How to Address
Non-specialist prescriber Transfer prescription to pulmonologist
Insufficient progression data Provide serial PFTs showing decline
Missing HRCT documentation Submit complete radiology reports
Step therapy not met Document pirfenidone failure/contraindication
Diagnosis not confirmed Provide comprehensive pulmonologist evaluation

Internal Appeals Process

Level 1 Appeal (180 days from denial)

  • Submit via UnitedHealthcare provider portal or member portal
  • Include all original documentation plus new supporting evidence
  • Request peer-to-peer review with UnitedHealthcare medical director
  • Standard decision: 30 days; expedited: 72 hours

Level 2 Appeal (60 days from Level 1 denial)

  • Higher-level internal review
  • Include additional specialist opinions or literature
  • Consider involving patient advocacy groups

Pennsylvania's External Review Process

Pennsylvania launched its Independent External Review Program in January 2024, giving patients powerful new appeal rights. In the program's first year, 50% of appealed denials were overturned.

How It Works

Eligibility: Must complete UnitedHealthcare's internal appeals first and receive a Final Adverse Benefit Determination Letter.

Timeline: Submit request within 4 months of final denial via the Pennsylvania Insurance Department website.

Process:

  • PID confirms eligibility within 5 business days
  • Independent review organization assigned within 1 business day
  • Submit additional evidence within 15 business days
  • Decision within 45 days (72 hours for expedited cases)

Cost: Free to consumers; insurers pay review fees

Results: If overturned, UnitedHealthcare must provide coverage immediately, including retroactive coverage if you paid out-of-pocket.

Note: This process only applies to commercial insured plans, not self-funded employer plans.

Contact Information

Renewal and Re-Authorization

UnitedHealthcare approves Ofev for 12-month periods. Start the renewal process 30-60 days before expiration.

Reauthorization Requirements

  • Positive clinical response: Stable or improved PFTs, reduced exacerbations
  • Continued specialist management: Ongoing pulmonologist care
  • Safety monitoring: Evidence of appropriate monitoring for side effects
  • No concurrent Esbriet use: Cannot be combined with pirfenidone

Document treatment response with:

  • Comparative PFT results
  • Functional status assessments
  • Hospitalization/exacerbation records
  • Quality of life measures

Cost Assistance Options

Manufacturer Support

Boehringer Ingelheim Access Support

  • Prior authorization assistance
  • Appeals support
  • Financial assistance programs
  • Contact: Ofev Access Support

Additional Resources

  • CareConnect4Me: Boehringer Ingelheim's patient support program
  • BI Cares: Financial assistance for eligible patients
  • State pharmaceutical assistance programs: Check Pennsylvania-specific options

Quick Reference Checklist

Before Starting:

  • Verify commercial vs. self-funded plan type
  • Confirm pulmonologist is prescriber
  • Gather HRCT reports (past 6-12 months)
  • Collect serial PFT results
  • Document prior treatment history

Submission:

  • Complete UnitedHealthcare PA form
  • Include comprehensive medical necessity letter
  • Attach all supporting clinical documentation
  • Submit via provider portal or fax
  • Request expedited review if urgent

Follow-Up:

  • Check status within 3-5 days
  • Document all interactions
  • Respond promptly to information requests
  • Prepare appeal documents if denied

If Denied:

  • File internal appeal within 180 days
  • Request peer-to-peer review
  • Gather additional supporting evidence
  • Consider Pennsylvania external review after internal appeals

Frequently Asked Questions

How long does UnitedHealthcare PA take in Pennsylvania? Standard prior authorization decisions are made within 72 hours. Urgent requests receive decisions within 24 hours.

What if Ofev is non-formulary on my plan? Non-formulary medications can still be covered through the medical exception process. Work with your pulmonologist to document medical necessity.

Can I request an expedited appeal? Yes, if your condition poses an immediate threat to your health. Document the urgency in your appeal request.

Does step therapy apply if I've tried pirfenidone outside Pennsylvania? Prior treatment history from any state should count. Provide complete documentation of previous therapy trials and outcomes.

What happens if I switch UnitedHealthcare plans? You may need a new prior authorization. Contact your new plan to confirm coverage and transfer existing approvals.

Medical Disclaimer: This guide provides general information about insurance coverage and is not medical advice. Always consult with your healthcare provider about treatment decisions. Coverage policies may vary by specific plan and change over time.

Sources & Further Reading

For personalized assistance with prior authorizations and appeals, Counterforce Health provides evidence-based appeal letters and payer-specific guidance to help patients access the medications they need.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.